Hannah Wardill, NHMRC/Hospital Research Foundation Fellow and Lead of Supportive Oncology Research Group at SAHMRI/Uni AdelaideMASCC Board Member, shared a post by Passe and Williams Foundation on LinkedIn:
“Oral mucositis – painful ulceration and burning of the mouth – is one of the most debilitating side effects of radiation therapy.
For people undergoing treatment for head and neck cancer, it can strip away some of life’s simplest pleasures: eating, speaking, swallowing, and social connection.
Despite affecting the vast majority of patients, effective management options remain limited. Too often, the only way to reduce its burden is to reduce or interrupt radiation treatment itself.
With support from the Passe and Williams Foundation, our team is investigating a novel radioprotective strategy designed to prevent or reduce oral mucositis without compromising cancer control.”
Quoting Passe and Williams Foundation‘s post:
“Announcing the Passe and Williams Foundation FY26 Awardees!
We’re proud to be supporting some of Australia’s leading minds in ENT research, backing breakthroughs that could *reverse* hearing loss, relieve the pain of head and neck cancer treatment, and protect children from lifelong ear disease.
From the world-first inner ear “cell atlas”, and tackling the world’s most common cancer to AI-driven Menière’s research and the first Australian Facial Plastic and Reconstructive Surgery fellow at Stanford University, this year’s Awardees are redefining what’s possible in ENT care.
With more than $4.3 million in support, we’re backing bold ideas, clinical excellence, and the people working to change lives.”
Other articles featuring Hannah Wardill on OncoDaily.